PDS Biotechnology Future Growth
Future criteria checks 0/6
PDS Biotechnology is forecast to grow earnings and revenue by 22.9% and 65% per annum respectively while EPS is expected to grow by 28% per annum.
Key information
22.9%
Earnings growth rate
28.0%
EPS growth rate
| Biotechs earnings growth | 31.1% |
| Revenue growth rate | 65.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | -51 | -48 | 9 | 3 |
| 12/31/2025 | 0 | -64 | -61 | -37 | 4 |
| 12/31/2024 | N/A | -51 | -56 | -43 | 5 |
| 12/31/2023 | N/A | -43 | -34 | -34 | N/A |
| 9/30/2023 | N/A | -51 | -33 | -33 | N/A |
| 6/30/2023 | N/A | -48 | -31 | -31 | N/A |
| 3/31/2023 | N/A | -42 | -33 | -33 | N/A |
| 12/31/2022 | N/A | -41 | -26 | -26 | N/A |
| 9/30/2022 | N/A | -28 | -23 | -23 | N/A |
| 6/30/2022 | N/A | -28 | -22 | -22 | N/A |
| 3/31/2022 | N/A | -22 | -15 | -15 | N/A |
| 12/31/2021 | N/A | -17 | -12 | -12 | N/A |
| 9/30/2021 | N/A | -15 | -13 | -13 | N/A |
| 6/30/2021 | N/A | -12 | -9 | -9 | N/A |
| 3/31/2021 | N/A | -14 | -14 | -14 | N/A |
| 12/31/2020 | N/A | -15 | -13 | -13 | N/A |
| 9/30/2020 | N/A | -15 | -14 | -14 | N/A |
| 6/30/2020 | N/A | -17 | -17 | -17 | N/A |
| 3/31/2020 | N/A | -18 | -18 | -18 | N/A |
| 12/31/2019 | N/A | -7 | -18 | -18 | N/A |
| 9/30/2019 | N/A | -5 | -13 | -13 | N/A |
| 6/30/2019 | N/A | 0 | -9 | -9 | N/A |
| 3/31/2019 | N/A | 4 | -5 | -5 | N/A |
| 12/31/2018 | N/A | -4 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2017 | N/A | -3 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EU6 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EU6 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EU6 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EU6 is forecast to have no revenue next year.
High Growth Revenue: EU6 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EU6's Return on Equity is forecast to be high in 3 years time